1. The renal handling of lysine was studied during the intravenous infusion of a lysine load given in such a way that the plasma lysine concentration was constantly increasing. Theoretical renal thresholds, and maximum rates of renal tubular reabsorption of lysine, have been determined in three normal adults, five homozygous cystinuric patients, and three persons, two 'completely' and the third 'incompletely' recessive, heterozygotes for cystinuria. All the cystinuric patients were found to have thresholds at less than 1 mg of lysine/lOO ml of plasma; the thresholds of all three heterozygotes fell within the same range as those of the three normal persons, that is, at values only two to three times the fasting plasma lysine concentration.
Frances T. Lester and D . C. Cusworth patterns in heterozygotes, Rosenberg (1966) has suggested that cystinuria represents three genetically distinct diseases, the genes being allelic.
Various genetic studies to date have rested heavily on determinations of amino acid concentrations in single random urine specimens. Although the renal defect is thought to be due to an abnormality in a common transport mechanism for the amino acids concerned, no attempts have been made, in vivo, to measure the transport capacity for any one of them. Information obtained from animal studies indicates that the renal tubular amino acid transport is limited: in man, experimental determinations of the maximum rate of reabsorption (T,) of amino acids exist only for proline (Scriver, Efron & Schafer, 1964) and hydroxyproline (Scriver & Goldman, 1966) .
It was thought, therefore, that the determination, in normal persons, of the maximum rate of renal tubular reabsorption of one of the amino acids excreted abnormally in cystinuria, and the comparison of this with the rate found in both cystinuric patients and heterozygotes for the disease, might yield information of interest concerning the renal defect in cystinuria and the mode of inheritance of the disease.
Cystine cannot be given intravenously because of its low solubility; for this reason, and because lysine, which can safely be given intravenously (Robson & Rose, 1957) , shares increased excretion with cystine in the incompletely recessive heterozygote, lysine was the amino acid chosen for study.
M E T H O D S

Patients studied
The subjects were five cystinuric ('C) patients attending the Metabolic Clinic at University College Hospital, three parents of such patients, one incompletely recessive ('S') and two completely recessive ('H'), and three normal healthy doctors ("9. All volunteered to participate in the study after its nature had been fully explained to them. Pertinent clinical data and the 24 h amino acid excretion of the subjects is summarized in Table 1 , the 24 h collection of urine having been done on a day different to that of the infusion. Amino acid excretion of all living first-degree relatives was estimated qualitatively by high-voltage paper electrophoresis at pH 2 and pH 8.
Experimental
All lysine infusions were given in the morning after an overnight fast. The renal tubular threshold for lysine was determined using the method of Stamp & Stacey (1970) , developed for the measurement of phosphate thresholds. After a control period, a sterile 5% solution of Llysine monohydrochloride at pH 7.4 was administered intravenously, the flow being controlled by a peristaltic pump (Buchler Instruments Inc., Fort Lee, N.J., U.S.A.); the infusion rate was increased in equal steps at exactly 15 min intervals. With this technique, the plasma lysine concentration increases linearly with time ( Fig. 1) . Total doses ranged between 146 and 519 mg/kg administered over 2-3 h periods; no ill-effects occurred during any of the infusions.
Approximately six urine collections lasting 20-30 min were made during the lysine infusion, a venous blood specimen being taken at the midpoint of each collection period. All the subjects drank large amounts of water before and during the infusion to facilitate voiding at the required time. No correction of 'renal tract delay time ' (McSwiney & de Wardener, 1950) was made The subjects were as follows : C1-5, homozygous cystinuric subjects; S1, incomplete recessive heterozygote; HI-2, completely recessive heterozygotes; N1-3, normal subjects. -, No measurable peak on chromatogram.
* Values of inulin and creatinine clearance represent the average for all collection periods.
t Estimated from timed control urine specimen. in the timing of specimen collection, as this can be assumed to be approximately balanced by the use of venous blood and rapidly rising plasma concentrations (Brun, Hilden & Raaschou, 1949) . Inulin (or [51Cr]EDTA) clearance was determined simultaneously, the inulin solution being delivered through the same cannula at constant rate by a second pump, and creatinine clearance determinations were made for every collection period. In order to be certain that diuresis itself does not cause alteration in amino acid excretion, amino acid clearances were determined in three healthy fasting adults before and after the induction of a water diuresis.
Amino acid determinations were made with an automatic amino acid analyser (Locarte, London, S.W.7) using a 50 cm x 0.9 cm column of Zeocarb 225 resin, and the method of Spackman, Stein & Moore (1958) in which the recovery of amino acids varies between 94 and 104%. After picric acid precipitation of the protein, plasma samples were prepared by the method of Stein, Bearn & Moore (1954); urine specimens, of volume corresponding to periods varying from 0-5 min for control specimens to 04-0-4 s for final specimens, were placed directly on the column after acidification. Norleucine was used as an internal standard. The buffer programme was as follows : pH 3.25 at 35°C for 150 min, pH 4-25 at 60°C for 210 min, and pH 6.50 at 60°C for 240 min.
Plasma urea, and creatinine concentrations, and urinary creatinine content, were determined, using standard autoanalyser techniques, by the Clinical Chemistry Laboratory or the Metabolic Ward Laboratory of University College Hospital. Inulin concentrations were determined by Dr G. A. Rose of the Institute of Urology.
RESULTS
The data pertinent to the renal tubular handling of lysine are summarized in Table 2 and representative graphs appear in Figs. 2, 3 and 4.
The plasma venous threshold was determined by the line threshold method cited in Smith (1951) , and has been given as a range of possible extremes where uncertainty existed concerning the inclusion of certain initial points in the calculation of the regression line. The stated ranges were not calculated statistically.
The thresholds found are presented schematically in Fig. 5 . The maximum rates of reabsorption (Tm) were calculated from the threshold value, the estimated glomerular filtration rate, and the body surface area. Threshold values were felt to be more accurate estimates of the transport capacity for lysine than T,, since additional error is introduced by the use of glomerular filtration rate and body surface area in calculation of the latter. This is particularly true in the present study, where the difficulties of accurate determination of inulin and creatinine in the extremely dilute urine specimens led to difficulties in accurately calculating the glomerular filtration rate.
Lysine infusion had a marked effect on the excretion of cystine, arginine and ornithine, increasing their clearances in the normal subjects by up to fiftyfold (Table 3) . At the same time, it increased to two to three times of control values the excretion of many other amino acids. At the present time, there is no explanation for this latter effect. That it was not due to the induction of a water diuresis alone is shown in Table 4 , where it is demonstrated that amino acid excretion rates were remarkably constant in spite of tenfold changes in urine flow rates. 
DISCUSSION
Plasma venous thresholds, and maximal rates of renal tubular reabsorption (T,,,), are theoretical measurements only, but they do give a quantitative estimate of the renal tubular capacity for reabsorption of a solute. They yield no precise information concerning events at the luminal surface of the renal tubular cell, and such values represent an 'average' for the function of all nephrons. The plasma concentration at which a solute actually appears in the effluent of a given renal tubule will depend on such considerations as varying length of the proximal convoluted tubules (Hanssen, 1961) and possibly on varying capacities for transport from tubule to tubule. With the above points in mind, certain conclusions can be drawn. Thus, renal L-lysine reabsorption is limited in man, and it is possible to demonstrate theoretical thresholds in normal persons at plasma concentrations only twice to three times the normal fasting value.
A spread was seen in the titration curve for several subjects, as is seen in titration curves for renal handling of glucose (Oliver & MacDowell, 1961) . All five homozygous cystinuric patients had theoretical thresholds at about 1 mg of lysine/100 ml or less, as would be expected in these persons who excrete large amounts of lysine under ordinary circumstances. 
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Two subjects who were 'completely recessive' heterozygotes for cystinuria had lysine thresholds virtually the same as those of two of the normal subjects, and greater than that of the third normal person. In other words, any alteration in their renal lysine transport mechanism consequent to their heterozygous state was not identifiable by this technique. This observation may be contrasted with transport capacities midway between those of normal and homozygous persons in heterozygotes for iminoglycinuria (Scriver et al., 1964) .
The one 'incompletely recessive' heterozygote studied (Sl, E.W.) had a threshold virtually the same as that of one normal woman (Nl, F.L.), and thus appeared to fall within the normal range. It is interesting to note that in the fasting control period, he excretes 0.9 mg of lysine/mg whereas she excretes only 0.05 mglmin: it could be postulated that this is due to differences in the spread of the titration curve. As mentioned above, Harris et al. (1955) divided the heterozygotes for cystinuria into two distinct groups on the basis of differences in cystine and lysine content of their urine, and concluded that there were two separate genes, probably allelic, each in the homozygous state giving rise to the phenotype 'cystinuria'. However, they suggested another possible explanation in terms of a single gene whose expression in the heterozygous situation is modified by the action of unrelated genes at other loci. Crawhall, Saunders & Thompson (1966) , finding it difficult to separate heterozygotes on the basis of cystine and lysine excretion, suggested that arginine excretion was a better marker. On the other hand, Rosenberg, Downing, Durrant & Segal(1966a) have concluded that cystinuria represents three distinct diseases due to three separate allelic mutations : these conclusions are based on studies of radioactive amino acid uptake in isolated jejunal and renal tissue from cystinuric patients, determination of amino acid excretion of heterozygotes (Rosenberg, Durrant & Albrecht, 1966b) and studies of absorption of oral cystine loads in homozygotes (Rosenberg, Durrant & Holland, 1965) . The original determinations of the cystine and lysine excretion of heterozygotes for cystinuria were made by microbiological techniques. All determinations made by the newer, more accurate technique of automatic amino acid chromatography which can be found in the literature have been plotted after the manner of Harris et al. (1955) . In Fig. 6 a wide range is found, with clustering towards normal. This, in addition to the present finding of increased resting lysine excretion in a heterozygote whose renal threshold for lysine apparently lies within a normal range, suggests that Harris' (1955) alternative hypothesis may best explain the variation in heterozygotes for cystinuria. In other words, whether or not the heterozygous state is manifest as an abnormal urinary amino acid pattern may depend on aspects of renal function other than the presence of heterozygosity for cystinuria. However, the number of subjects in the present study is too small to allow one to draw any further conclusions regarding the genetics of cystinuria. The study again demonstrates, as shown initially by Robson & Rose (1957) using paperchromatographic techniques, that the administration of lysine to normal persons increases markedly the excretion of cystine, arginine and ornithine. Clearance measurements of cystine, lysine, arginine and ornithine during control and final infusion periods in the subjects we studied are given in Table 3 . Measurements during intermediate periods, not included in Table 3 , also indicate that cystine, arginine and ornithine only begin to appear in the urine in significant quantities after the plasma threshold for lysine is passed; the increase in their clearance was never as great as that of lysine. It has been stated that any remaining mechanism for cystine, lysine, arginine and ornithine reabsorption in cystinuria cannot be further inhibited by lysine administration (Scriver, 1967) . However, the clearance of all three has been substantially increased by the infusion of lysine in three of the homozygous cystinurics in this study (C3, G.W.; C4, H.H.; and C5, E.D.) without changes in plasma cystine and ornithine concentration and with increases in plasma arginine concentration of only about 1 mg/100 ml. This is in contrast with the finding of Scriver et al. (1964) in homozygous iminoglycinuria, where the retained glycine reabsorption could not be inhibited by excess of proline and hydroxyproline. Rosenberg, Albrecht & Segal(l967) have demonstrated the presence of two different transport systems for lysine in human kidney, but only one system was common with cystine, arginine and ornithine. Unless a third system is postulated, also common for the four amino acids, our data suggests a qualitative alteration in a common transport mechanism, rather than its deletion, in cystinuria.
